Company Filing History:
1 out of 26 
3 out of 832,891 Years Active: 2013-2017
Title: Peter Spargo: Innovator in Pharmaceutical Chemistry
Introduction
Peter Spargo is a notable inventor based in Deal, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work primarily focuses on novel crystalline forms of compounds that have potential applications in treating bacterial infections.
Latest Patents
Among his latest patents is the invention related to crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt. This invention describes novel crystalline forms of the sodium salt of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide, also known as NXL-104. The patent outlines compositions that include this crystalline form, either alone or in combination with antibacterial agents such as ceftaroline fosamil. Additionally, it details processes for preparing these crystalline forms and methods for treating bacterial infections using them.
Career Highlights
Peter Spargo has worked with various organizations throughout his career, including Forest Laboratories Holdings Limited. His expertise in pharmaceutical chemistry has allowed him to develop innovative solutions that address critical health challenges.
Collaborations
Peter has collaborated with notable professionals in his field, including Mahendra G Dedhiya and Sisir Bhattacharya. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Peter Spargo's contributions to pharmaceutical chemistry through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to influence the field and offers promising avenues for future research and development.